These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2295065)
1. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide. Schroy PC; Carnright K; Winawer SJ; Friedman EA Cancer Res; 1988 Oct; 48(19):5487-94. PubMed ID: 2458179 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Hafez MM; Infante D; Winawer S; Friedman E Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877 [TBL] [Abstract][Full Text] [Related]
4. Two roles for transforming growth factor beta 1 in colon enterocytic cell differentiation. Hafez MM; Hsu S; Yan Z; Winawer S; Friedman E Cell Growth Differ; 1992 Nov; 3(11):753-62. PubMed ID: 1334691 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA; Ziober BL; Morris SL; Mulder KM Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905 [TBL] [Abstract][Full Text] [Related]
6. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. Schroy PC; Rustgi AK; Ikonomu E; Liu XP; Polito J; Andry C; O'Keane JC J Cell Physiol; 1994 Oct; 161(1):111-23. PubMed ID: 7929596 [TBL] [Abstract][Full Text] [Related]
7. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253 [TBL] [Abstract][Full Text] [Related]
8. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S; Tobon A; Varani J; Brattain MG Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state. Mulder KM Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589 [TBL] [Abstract][Full Text] [Related]
10. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724 [TBL] [Abstract][Full Text] [Related]
11. Induction of carcinoembryonic antigen and its crossreactive gene products in human colonic adenomas and carcinomas by transforming growth factor-beta. Chakrabarty S; Mustain S; Willson JK Mol Biother; 1990 Mar; 2(1):27-31. PubMed ID: 2334536 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line. Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320 [TBL] [Abstract][Full Text] [Related]
13. Growth factor production by human colon carcinoma cell lines. Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895 [TBL] [Abstract][Full Text] [Related]
14. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line. Levine AE; Black B; Brattain MG J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796 [TBL] [Abstract][Full Text] [Related]
15. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169 [TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines. Hébert CD; Birnbaum LS Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899 [TBL] [Abstract][Full Text] [Related]
18. Activin A inhibits growth and hexamethylene bisacetamide-induced differentiation in human retinoblastoma Y-79 cells. Zhang Z; Batres Y; Ying SY Anticancer Res; 1996; 16(1):269-72. PubMed ID: 8615619 [TBL] [Abstract][Full Text] [Related]
19. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Picon A; Gold LI; Wang J; Cohen A; Friedman E Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494 [TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor beta 1 by human endometrial carcinoma cell lines: inverse correlation with effects on growth rate and morphology. Boyd JA; Kaufman DG Cancer Res; 1990 Jun; 50(11):3394-9. PubMed ID: 2334934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]